Interesting, market cap was 195M in 2015, to 5B in 2019, when it was bought out for 6B. I assume the great response rate in the basket trial had something to do with that market cap increase.

Eli Lilly (NYSE:LLY) has completed its acquisition of 26,043,820 common shares of Loxo Oncology (NASDAQ:LOXO) at $235 per share for a total of ~$6.12B, representing an 84.6% stake. Lilly will acquire the remaining non-tendered shares through a second-step merger.